About 21 percent of adults diagnosed with acute PE in primary care sent home; few experienced adverse events within 30 days
TUESDAY, Jan. 25, 2022 (HealthDay News) — Comprehensive clinic-based care may be acceptable for carefully selected adults diagnosed with acute pulmonary embolism in the primary care setting, according to a study published online Jan. 12 in the Journal of General Internal Medicine.
David R. Vinson, M.D., from the Permanente Medical Group in Oakland, California, and colleagues describe 30-day outcomes stratified by initial site-of-care decisions in a multicenter retrospective cohort study involving adults diagnosed with acute pulmonary embolism in primary care. Data were included for 652 patient encounters from 646 patients (median age, 64 years; 51.5 percent male).
The researchers found that 20.6 percent of cases were sent home from primary care and 79.4 percent were initially referred to the emergency department or hospital. Overall, 37.8 percent of those who were initially referred were discharged home without events. A 30-day serious adverse event was experienced by eight patients (1.2 percent) and included venous thromboembolism, major bleed, and death (four, one, and three patients, respectively). Of these patients, seven were initially hospitalized and one had been sent home from primary care. The three deaths occurred in patients with known metastatic cancer who were initially referred to the emergency department, hospitalized, and subsequently enrolled in hospice. About half (50.3 percent) of the patients were hospitalized within seven days: 322 and six at the time of index diagnosis and following initial outpatient management, respectively.
“These results suggest that community-based primary care clinicians can manage patients with acute pulmonary embolism safely and effectively,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer
Cancer Survivors Have Lower Levels of Physical Activity
Childhood Cancer Survivors Often Have Mental Distress in Adulthood
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis